BANK VONTOBEL/CALL/MERCK & CO./140/0.1/20.12.24 Share Price

Warrant

DE000VD3SE22

Market Closed - Boerse Frankfurt Warrants 19:08:02 31/05/2024 BST
0.28 EUR -15.15% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./140/0.1/20.12.24
Current month-40.43%
1 month-40.43%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/05/24 0.28 -15.15%
30/05/24 0.33 +17.86%
29/05/24 0.28 -3.45%
28/05/24 0.29 -23.68%
27/05/24 0.38 -2.56%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 07:08 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SE2
ISINDE000VD3SE22
Date issued 09/04/2024
Strike 140 $
Maturity 20/12/2024 (203 Days)
Parity 10 : 1
Emission price 0.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.57
Lowest since issue 0.28
Spread 0.01
Spread %3.33%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus